Twist Bioscience Corp. (TWST)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Mar 12, 2025

$39.32

P/E Ratio

N/A

Market Cap

$2.35B

Mar 19, 2024Apr 23, 2024May 29, 2024Jul 2, 2024Aug 2, 2024Sep 5, 2024Oct 8, 2024Nov 11, 2024Dec 17, 2024Jan 24, 2025Mar 12, 2025$20.00$30.00$40.00$50.00$60.00
  • TWST
Description
Add to research

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Metrics
Add to research

Overview

  • HQSan Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerTWST
  • Price$39.32+0.49%

Trading Information

  • Market cap$2.35B
  • Float94.49%
  • Average Daily Volume (1m)1,261,759
  • Average Daily Volume (3m)970,801
  • EPS-$3.38

Company

  • Revenue$330.19M
  • Rev growth (1yr)24.08%
  • Net income-$31.59M
  • Gross margin48.29%
  • EBITDA margin-31.86%
  • EBITDA-$28.26M
  • EV$2.56B
  • EV/Revenue7.76
  • P/EN/A
  • P/S7.05
  • P/B5.14
  • Debt/Equity18.12
Documents
Add to research